What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question.
Basile V, Puglisi S, Altieri B, Canu L, Libè R, Ceccato F, Beuschlein F, Quinkler M, Calabrese A, Perotti P, Berchialla P, Dischinger U, Megerle F, Baudin E, Bourdeau I, Lacroix A, Loli P, Berruti A, Kastelan D, Haak HR, Fassnacht M, Terzolo M.
Basile V, et al. Among authors: dischinger u.
J Pers Med. 2021 Apr 4;11(4):269. doi: 10.3390/jpm11040269.
J Pers Med. 2021.
PMID: 33916613
Free PMC article.